Patents by Inventor Laura Deveau

Laura Deveau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds specific to coronavirus S protein and uses thereof
    Patent number: 11414479
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: August 16, 2022
    Assignee: Adagio Therapeutics, Inc.
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo
  • COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF
    Publication number: 20220153815
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Application
    Filed: December 1, 2021
    Publication date: May 19, 2022
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo
  • COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF
    Publication number: 20220010002
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Application
    Filed: August 18, 2021
    Publication date: January 13, 2022
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo
  • Compounds specific to coronavirus S protein and uses thereof
    Patent number: 11220536
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: January 11, 2022
    Assignee: Adagio Therapeutics, Inc.
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo
  • COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF
    Publication number: 20210388067
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Application
    Filed: August 18, 2021
    Publication date: December 16, 2021
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo
  • Compounds specific to coronavirus S protein and uses thereof
    Patent number: 11192940
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: December 7, 2021
    Assignee: Adagio Therapeutics, Inc.
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo
  • COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF
    Publication number: 20210324048
    Abstract: The present disclosure is directed to antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein of the SARS coronavirus (SARS-CoV-S) and/or the S protein of the SARS coronavirus 2 (SARS-CoV-2-S), including neutralizing antibodies and antibodies that bind to and/or compete for binding to the same linear or conformational epitope(s) on CoV-S. Further disclosed are conjugates of anti-CoV-S antibodies, and binding fragments thereof, conjugated to one or more functional or detectable moieties. Methods of making said anti-CoV-S antibodies and antigen binding fragments thereof are also contemplated.
    Type: Application
    Filed: April 9, 2021
    Publication date: October 21, 2021
    Inventors: Laura Walker, Laura Deveau, Jonathan Belk, Anna Wec, C. Garrett Rappazzo